Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology

International Journal of Pharmaceutics

Volumn 422, Issue 1-2, 2012, Pages 516-522

  Liu, Guangpu ^a   Zhang, Dianrui ^a   Jiao, Yang ^a   Zheng, Dandan ^a   Liu, Yue ^a   Duan, Cunxian ^a   Jia, Lejiao ^a   Zhang, Qiang ^b   Lou, Hongxiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Dissolution rate; Evaporative precipitation into aqueous solution; Microfluidisation; Nanocrystal; Riccardin D; Stable

Indexed keywords

NANOCRYSTAL; PLANT EXTRACT; RICCARDIN D; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON MICROSCOPE; MARCHANTIA; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; X RAY DIFFRACTION; ZETA POTENTIAL;

ANTIFUNGAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; DRUG COMPOUNDING; DRUG STABILITY; ETHANOL; EXCIPIENTS; KINETICS; MASS SPECTROMETRY; METHYLCELLULOSE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PHENYL ETHERS; POLOXAMER; POVIDONE; POWDER DIFFRACTION; PRESSURE; SOLUBILITY; SOLVENTS; STILBENES; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; WATER;

EID: 84655168064     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.11.025     Document Type: Article

References (24)

1. H.S.M. Ali, P. York, and N. Blagden Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors Int. J. Pharm. 375 2009 107 113
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharm. Res. 12 1995 413 420
3. B.H. Bohm, and R.H. Muller Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs Pharm. Sci. Technol. Today 2 1999 336 339 (Pubitemid 29378538)
4. S. Branchu, P.G. Rogueda, A.P. Plumb, and W.G. Cook A decision-support tool for the formulation of orally active, poorly soluble compounds Eur. J. Pharm. Sci. 32 2007 128 139 (Pubitemid 47299301)
5. H. Chen, C. Khemtong, X. Yang, X. Chang, and J. Gao Nanonization strategies for poorly water-soluble drugs Drug Discov. Today 16 2011 354 360
6. H. Chen, J. Wan, Y. Wang, D. Mou, H. Liu, H. Xu, and X. Yang A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions Nanotechnology 19 2008 375104
7. X. Chen, T.J. Young, M. Sarkari, R.O. Williams 3rd, and K.P. Johnston Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution Int. J. Pharm. 242 2002 3 14
8. H. de Waard, W.L. Hinrichs, and H.W. Frijlink A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying J. Control. Release 128 2008 179 183
9. L. Gao, G. Liu, X. Wang, F. Liu, Y. Xu, and J. Ma Preparation of a chemically stable quercetin formulation using nanosuspension technology Int. J. Pharm. 404 2011 231 237
10. D. Horn, and J. Rieger Organic nanoparticles in the aqueous phase - theory, experiment, and use Angew. Chem. Int. Ed. Engl. 40 2001 4330 4361 (Pubitemid 33150759)
11. J. Hu, W.K. Ng, Y. Dong, S. Shen, and R.B.H. Tan Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying Int. J. Pharm. 404 2011 198 204
12. C. Keck, and R. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
13. M.S. Kim, S.J. Jin, J.S. Kim, H.J. Park, H.S. Song, R.H. Neubert, and S.J. Hwang Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process Eur. J. Pharm. Biopharm. 69 2008 454 465
14. M. Kondo, T. Niwa, H. Okamoto, and K. Danjo Particle characterization of poorly water-soluble drugs using a spray freeze drying technique Chem. Pharm. Bull. (Tokyo) 57 2009 657 662
15. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
16. R.H. Muller, C. Jacobs, and O. Kayser Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future Adv. Drug Deliv. Rev. 47 2001 3 19 (Pubitemid 32209229)
17. V.B. Patravale, A.A. Date, and R.M. Kulkarni Nanosuspensions: a promising drug delivery strategy J. Pharm. Pharmacol. 56 2004 827 840 (Pubitemid 38885975)
18. K. Peters, S. Leitzke, J.E. Diederichs, K. Borner, H. Hahn, R.H. Muller, and S. Ehlers Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection J. Antimicrob. Chemother. 45 2000 77 83 (Pubitemid 30060237)
19. N. Rasenack, and B.W. Muller Micron-size drug particles: common and novel micronization techniques Pharm. Dev. Technol. 9 2004 1 13 (Pubitemid 38258252)
20. Y.-q. Shi, X.-j. Qu, Y.-x. Liao, C.-f. Xie, Y.-n. Cheng, S. Li, and H.-x. Lou Reversal effect of a macrocyclic bisbibenzyl plagiochin E on multidrug resistance in adriamycin-resistant K562/A02 cells Eur. J. Pharmacol. 584 2008 66 71
21. Y. Wang, D. Zhang, Z. Liu, G. Liu, C. Duan, L. Jia, F. Feng, X. Zhang, Y. Shi, and Q. Zhang In vitroandin vivoevaluation of silybin nanosuspensions for oral and intravenous delivery Nanotechnology 21 2010 155104
22. X.-Z. Wu, W.-Q. Chang, A.-X. Cheng, L.-M. Sun, and H.-X. Lou Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway Biochim. Biophys. Acta Gen. Subjects 1800 2010 439 447
23. X.-Z. Wu, A.-X. Cheng, L.-M. Sun, S.-J. Sun, and H.-X. Lou Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans Biochim. Biophys. Acta Gen. Subjects 1790 2009 770 777
24. J. Xing, B. Lv, C. Xie, J. Qu, and H. Lou Liquid chromatography-tandem mass spectrometry assay for the quantitation of plagiochin E and its main metabolite plagiochin E glucuronides in rat plasma J. Pharm. Biomed. Anal. 47 2008 949 953